RE:RE:RE:RE:RE:Next week?Hey palinc ... I hope you are right. But I'm curious, is this pure conjecture or have you "heard something"?
-LT
palinc2000 wrote: I think I am leaning towards a Nash partnership but hey I would welcome any positive news .....I am also looking at the calendar and I think Dec 15 might be the last day in 2021nto release good news and leave enough time for the market to digest it and give it the attention it deserves before the Holidays
SPCEO1 wrote: Are you thinking NASH and/or cancer partnership news? New drug acquisition? I could see there being cancer partnership news from China or Western drug companies even before we get the news of how the phase 1a ended.
Celarly, the options grant tells us some good news is coming. It does not tell us exactly when it will be announced, what that news might be or how significant the market might view it, but some degree of good news is on the way.
It seems to me there is a good chance they have now seen some sign of tumor regression at the roughly 2x the normal Docetaxel dose. If they were fortunate to get at least two sortilin overexpressing patients in that dosage level and they had two different types of cancer and they saw responses in both, than that would be very good news indeed.
palinc2000 wrote: Positive news could come from other fronts also ......
SPCEO1 wrote: If the trial is going to go into January, they really should give us an update prior to Christmas.
palinc2000 wrote: Crossing my fingers for positive news ,,,